PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 28.6 CHF -0.52% Market Closed
Market Cap: 943.3m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

Gross Margin
PolyPeptide Group AG

9.3%
Current
17%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
9.3%
=
Gross Profit
30.3m
/
Revenue
327.3m

Gross Margin Across Competitors

Country CH
Market Cap 943.3m CHF
Gross Margin
9%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 202.3B USD
Gross Margin
41%
Country US
Market Cap 166.6B USD
Gross Margin
60%
Country KR
Market Cap 66.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.8B USD
Gross Margin
55%
Country US
Market Cap 36.3B USD
Gross Margin
35%
Country US
Market Cap 27B USD
Gross Margin
59%
Country US
Market Cap 24.1B USD
Gross Margin
35%
Country CN
Market Cap 164.6B CNY
Gross Margin
40%
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
943.3m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
27.95 CHF
Overvaluation 2%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
9.3%
=
Gross Profit
30.3m
/
Revenue
327.3m
What is the Gross Margin of PolyPeptide Group AG?

Based on PolyPeptide Group AG's most recent financial statements, the company has Gross Margin of 9.3%.